Bio-Techne Patents – Insights & Stats

Bio-Techne has a total of 993 patents globally, out of which 427 have been granted. Of these 993 patents, 50% patents are active. United States Of America is where Bio-Techne has filed the maximum number of patents, followed by Europe and China. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Bio-Techne.

Bio-Techne was founded in 1976 by Roger C. Lucas. Bio-Techne develops, manufactures and sells biotechnology products and clinical diagnostic controls. The Company specializes in proteins, cytokines, growth factors, immunoassays and small molecules. As of May 2022, Bio-Techne has a market cap of $14.20 Billion.

Do read about some of the most popular patents of Bio-Techne which have been covered by us in this article and also you can find Bio-Techne patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bio-Techne patent portfolio.

How many patents does the Founder and CEO of Bio-Techne have?

The Founder Roger C. Lucas has 11 and CEO, Charles R. Kummeth has 0 patents.

How many patents does Bio-Techne have?

Bio-Techne has a total of 993 patents globally. These patents belong to 277 unique patent families. Out of 993 patents, 498 patents are active.

How Many Patents did Bio-Techne File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBio-Techne Applications FiledBio-Techne Patents Granted
2010575
20115514
2012466
20137016
20147661
20154555
20165327
20178330
20185531
20195258
20203338
20212436
2022118

How many Bio-Techne patents are Alive/Dead?

Worldwide Patents

How Many Patents did Bio-Techne File in Different Countries?

Countries in which Bio-Techne Filed Patents

CountryPatents
United States Of America254
Europe156
China76
Germany75
Japan56
Canada54
Australia48
Spain31
Israel23
Hong Kong (S.A.R.)11
Korea (South)11
Denmark10
Brazil7
India7
Singapore7
Austria4
South Africa3
Russia3
Norway2
United Kingdom2
Mexico2
Slovenia1
Taiwan1
Macao1
Poland1

Where are Research Centers of Bio-Techne Patents Located?

10 Best Bio-Techne Patents

US6605451B1 is the most popular patent in the Bio-Techne portfolio. It has received 342 citations so far from companies like Applera Corporation and Life Technologies.

Below is the list of 10 most cited patents of Bio-Techne:

Publication NumberCitation Count
US6605451B1342
US20090092974A1179
US20020028488A1148
US20040110191A1144
US7709198B2135
WO2008073915A2130
US20090263803A1118
US20060078894A1117
US20090081688A191
US7888010B278

What Percentage of Bio-Techne US Patent Applications were Granted?

Bio-Techne (Excluding its subsidiaries) has filed 27 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 16 have been granted leading to a grant rate of 80.00%.

Below are the key stats of Bio-Techne patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Bio-Techne?

Law FirmTotal ApplicationsSuccess Rate
Fredrikson & Byron1573.33%
Mueting Raasch Group10100.00%
Casimir Jones10%
Phillip M Goldman1100.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Bio-Techne key innovation segments?

What Technologies are Covered by Bio-Techne?

The chart below distributes patents filed by Bio-Techne in different countries on the basis of the technology protected in patents. It also represents the markets where Bio-Techne thinks it’s important to protect particular technology inventions.

R&D Focus: How has Bio-Techne‘s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Bio-Techne?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.